BSX

#165
Boston Scientific Corp.
63.79 USD
+1.24%
Сектор: Здравоохранение
Базовая: USD
Валюта прибыли: USD
Дневной диапазон
63.76
63.99
Годовой диапазон
60.59
109.49
Дневное изменение
+1.24%
Месячное изменение
-7.79%
6-месячное изменение
-33.47%
Годовое изменение
-32.70%
Предыдущее закрытие
63.01
Открыть
63.93
Bid
Ask
Минимум
63.76
High
63.99
Объем
2 118
Открыть полный график

Financials

Обзор Отчетность Статистика
Квартал Год
  • Market Capitalization 94.66 B
  • Employee 59 K
  • Founded 1979
  • CEO Michael F. Mahoney
  • Website www.bostonscientific.com
  • Headquarter Delaware, United States
  • FIGI BBG000C0LW92
  • Industry Technology
Общий доход
Чистая прибыль
Базовая прибыль на акцию
Общий долг
Свободный денежный поток
Денежные средства и эквиваленты
Коэффициент цена/прибыль
49.15
Коэффициент цена/денежный поток
7.1

Boston Scientific Corporation

Boston Scientific Corporation is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology. The company is known for the development of the Taxus Stent, a drug-eluting stent which is used to open clogged arteries. The company acquired Cameron Health in June 2012 and began to offer a minimally invasive implantable cardioverter-defibrillator called the EMBLEM subcutaneous implantable defibrillator. Over the last 20 years, Boston Scientific has had some high-profile patent infringement cases. It has made extensive payouts, including $1.725 billion to Johnson & Johnson, $85 million to Nevro and $42 million to TissueGen. BSC is headquartered in Marlborough, Massachusetts and incorporated in Delaware.

Новости